These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8157304)

  • 1. Effect of hemoglobin on the growth of mycobacteria and the production of siderophores.
    Raghu B; Sarma CR; Venkatesan P
    Indian J Pathol Microbiol; 1993 Oct; 36(4):376-82. PubMed ID: 8157304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of iron on the growth and siderophore production of mycobacteria.
    Raghu B; Sarma GR; Venkatesan P
    Biochem Mol Biol Int; 1993 Oct; 31(2):341-8. PubMed ID: 8275022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of anti-tuberculosis drugs on the iron-sequestration mechanisms of mycobacteria.
    Raghu B; Sarma GR; Venkatesan P
    Indian J Pathol Microbiol; 1995 Jul; 38(3):287-92. PubMed ID: 8819661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Utilization of siderophores from mycobacteria by Staphylococcus].
    Szarapińska-Kwaszewska J; Mikucki J
    Med Dosw Mikrobiol; 1998; 50(3-4):239-49. PubMed ID: 10222739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of siderophores and envelope proteins from mycobacteria.
    Raghu B; Sarma GR
    Biochem Mol Biol Int; 1993 Oct; 31(2):333-9. PubMed ID: 8275021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inability to detect mycobactin in mycobacteria-infected tissues suggests an alternative iron acquisition mechanism by mycobacteria in vivo.
    Lambrecht RS; Collins MT
    Microb Pathog; 1993 Mar; 14(3):229-38. PubMed ID: 8321124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron uptake processes in Mycobacterium vaccae R877R, a mycobacterium lacking mycobactin.
    Messenger AJ; Hall RM; Ratledge C
    J Gen Microbiol; 1986 Mar; 132(3):845-52. PubMed ID: 2942636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal analogues of mycobactin and exochelin fail to act as effective antimycobacterial agents.
    Barclay R; Ratledge C
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Aug; 262(2):203-7. PubMed ID: 3097987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exochelins of Mycobacterium tuberculosis remove iron from human iron-binding proteins and donate iron to mycobactins in the M. tuberculosis cell wall.
    Gobin J; Horwitz MA
    J Exp Med; 1996 Apr; 183(4):1527-32. PubMed ID: 8666910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron acquisition by Mycobacterium tuberculosis: isolation and characterization of a family of iron-binding exochelins.
    Gobin J; Moore CH; Reeve JR; Wong DK; Gibson BW; Horwitz MA
    Proc Natl Acad Sci U S A; 1995 May; 92(11):5189-93. PubMed ID: 7761471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron-binding compounds of Mycobacterium avium, M. intracellulare, M. scrofulaceum, and mycobactin-dependent M. paratuberculosis and M. avium.
    Barclay R; Ratledge C
    J Bacteriol; 1983 Mar; 153(3):1138-46. PubMed ID: 6826517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobactins and exochelins of Mycobacterium tuberculosis, M. bovis, M. africanum and other related species.
    Barclay R; Ratledge C
    J Gen Microbiol; 1988 Mar; 134(3):771-6. PubMed ID: 3141575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobactin-mediated iron acquisition within macrophages.
    Luo M; Fadeev EA; Groves JT
    Nat Chem Biol; 2005 Aug; 1(3):149-53. PubMed ID: 16408019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of exochelins for iron transport in three species of mycobacteria.
    Stephenson MC; Ratledge C
    J Gen Microbiol; 1980 Feb; 116(2):521-3. PubMed ID: 6989958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of iron on the growth inhibition of pathogenic strains of mycobacterium avium and M. paratuberculosis in serum.
    Barclay R; Ratledge C
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Aug; 262(2):189-94. PubMed ID: 3788345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and studies of catechol-containing mycobactin S and T analogs.
    Walz AJ; Möllmann U; Miller MJ
    Org Biomol Chem; 2007 May; 5(10):1621-8. PubMed ID: 17571193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterial Esx-3 is required for mycobactin-mediated iron acquisition.
    Siegrist MS; Unnikrishnan M; McConnell MJ; Borowsky M; Cheng TY; Siddiqi N; Fortune SM; Moody DB; Rubin EJ
    Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18792-7. PubMed ID: 19846780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular iron acquisition by mycobacteria: role of the exochelins and evidence against the participation of mycobactin.
    Macham LP; Ratledge C; Nocton JC
    Infect Immun; 1975 Dec; 12(6):1242-51. PubMed ID: 1107222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The occurrence of carboxymycobactin, the siderophore of pathogenic mycobacteria, as a second extracellular siderophore in Mycobacterium smegmatis.
    Ratledge C; Ewing M
    Microbiology (Reading); 1996 Aug; 142 ( Pt 8)():2207-12. PubMed ID: 8800816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The exochelins of pathogenic mycobacteria: unique, highly potent, lipid- and water-soluble hexadentate iron chelators with multiple potential therapeutic uses.
    Horwitz LD; Horwitz MA
    Antioxid Redox Signal; 2014 Dec; 21(16):2246-61. PubMed ID: 24684595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.